Location
United States, North America
Cheque size
$2M - $50M
Investment Stage
Seed
Series A
Focus Areas
Health IT
Health & Hospital Services
BioTech
About Investor
Michele Park, PhD, is a Partner at New Enterprise Associates (NEA) on the Healthcare team, focused on biopharma. NEA invests across Seed, Series A, and Series B+ and writes checks ranging from $500K up to $50M. Before NEA, she was an investor at Clarus Ventures (now part of Blackstone Life Sciences) and worked as a biotechnology research analyst at Credit Suisse and Piper Jaffray. She holds a PhD in molecular biology from Weill Cornell (with dissertation work at Memorial Sloan Kettering) and a BA in molecular biology from Princeton.
Previous investments
Abcuro
200M |2025
Tagworks Pharmaceuticals
65M |2023
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,AL
Alicia Lenis
Canada, North America
$500K - $2M
Pre Seed
,Seed
,FB
Frank Balas
Canada, North America
$100K - $5M
Pre Seed
,Seed
,NP
Neil Peet
Canada, North America
$500K - $2M
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.